Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Atropos Health delivers immediate access to evidence derived from real-world data, effectively bridging the gaps in the healthcare and life sciences sectors. This innovative approach has been shown to enhance clinical outcomes, speed up research initiatives, and improve operational efficiency. By swiftly converting medical data into actionable real-world evidence, Atropos Health reduces the time needed for research from months to mere minutes. Central to its offerings is a generative evidence acceleration operating system that can securely incorporate and structure medical data for future applications. With robust analytics tools, users can generate evidence on demand, utilizing either their own data following a quick setup or tapping into our extensive global evidence network, which includes over 160 million patient records and a library of 10,000 prior studies. Partnering with Atropos Health allows leading health systems and life science organizations to fast-track research, refine clinical trials, enhance clinical decision-making, manage care variation effectively, and much more. Together, we are reshaping the future of healthcare through data-driven insights and collaborative innovation.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
API Access
Has API
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Atropos Health
Country
United States
Website
www.atroposhealth.com
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/